These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 648026)

  • 1. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
    Amlot PL; Pussell B; Slaney JM; Williams BD
    Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
    Brandeis WE; Tan C; Wang Y; Good RA; Day NK
    Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes as markers of Hodgkin's disease activity].
    Urbaniak-Kujda D
    Pol Tyg Lek; 1996 May; 51(19-22):303-4. PubMed ID: 9289719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.
    Long JC; Hall CL; Brown CA; Stamatos C; Weitzman SA; Carey K
    N Engl J Med; 1977 Aug; 297(6):295-9. PubMed ID: 559938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
    Brandeis WE; Helson L; Wang Y; Good RA; Day NK
    J Clin Invest; 1978 Dec; 62(6):1201-9. PubMed ID: 748375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes in the serum of patients with Hodgkin's disease].
    Berényi E; Kávai M; Pálkövi E; Szegedi G
    Orv Hetil; 1979 Jan; 120(2):79-82. PubMed ID: 760038
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating immune complexes and symptoms in Hodgkin's disease.
    Amlot PL; Slaney JM; Williams BD
    Lancet; 1976 Feb; 1(7957):449-51. PubMed ID: 55719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
    J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and sepsis.
    Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
    Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
    Yanase K; Imamura S
    Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical immune complex nephritis in patients with Hodgkin's disease.
    Sutherland JC; Markham RV; Ramsey HE; Mardiney MR
    Cancer Res; 1974 May; 34(5):1179-81. PubMed ID: 4276372
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1983 Aug; 53(2):308-18. PubMed ID: 6411401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of circulating immune complexes in glomerulonephritis.
    Valentijn RM; Daha MR; Van Es LA
    Neth J Med; 1984; 27(9):340-9. PubMed ID: 6392910
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
    Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
    Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.